SynBiotic SE

Research Updates

Christian Sandherr

18 Dec 24

The new group continues to take shape; chg. est.

Update
Christian Sandherr

17 Sep 24

SynBiotic transformation: Reaching new operational high(t)s

Initiation
Christian Sandherr

29 Aug 23

Gearing up to capitalize on favorable market dynamics; chg.

Update
Christian Sandherr

28 Dec 22

Strategic realignment to capitalize on cannabis legalization; chg.

Update

Downloads

Latest Research
Initiation

Analyst

Christian Sandherr

Equity Research

MailLinkedIn

Latest News

18.12.2024 13:06:47
EQS-News: Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis
18.12.2024 09:01:01
Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
25.11.2024 11:39:58
EQS-News: SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry
14.11.2024 13:30:41
EQS-News: In full bloom: WEECO Pharma boosts SYNBIOTIC's sales
27.09.2024 11:19:23
EQS-News: Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.